Key result
Low admission serum calcium was independently associated with a higher risk of all-cause mortality between 28 and 2500 days after acute myocardial infarction compared to normal-high calcium levels.
Why the study?
The possible role of serum calcium as a predictor for long-term mortality after acute myocardial infarction remained uncertain.
Does low admission serum calcium predict higher all-cause long-term mortality in patients surviving at least 28 days after an acute myocardial infarction?
Cohort (n=3,732)
Yes
Does low admission serum calcium predict higher all-cause long-term mortality in patients surviving at least 28 days after an acute myocardial infarction?
Low admission serum calcium is an independent predictor of increased all-cause mortality in the first 7 years following an acute myocardial infarction, suggesting it may serve as a marker of disease severity or risk.
Answers are grounded in this paper and cite their sources.
Low admission calcium was associated with higher post-AMI mortality; leaves open its role as a monitoring target or intervention point.
Calcium plays an essential role in physiology of the cardiovascular system. Aberrations from normal serum calcium levels are known to be associated with several cardiovascular diseases. Its possible role as a predictor for long-term mortality after acute myocardial infarction (AMI) is still uncertain. In this study, a total of 3732 patients (aged 25-74 years) with incident AMI surviving at least 28 days after AMI was included. The median follow-up time was 6.0 years. Admission total serum calcium levels were divided into quartiles. The Kaplan-Meier-Curve suggested a division of the follow up time in two different time periods. So, Cox regression models were calculated to assess association between admission serum calcium levels and all-cause long-term mortality with two observation periods: 28-2500 days and > 2500 days. The final model was adjusted for various comorbidities, clinical characteristics, in-hospital treatment and medication. The third quartile (normal-high Calcium levels) served as the reference group. The fully adjusted Cox-regression model shows significantly higher mortality risk for low serum calcium (quartile 1) within the timeframe 28-2500 days after the event (OR 1.53 [1.19-1.98]). The other groups did not differ significantly from each other. In the later observation period (from 2500 days until death or censoring) no more significant differences were seen between the four calcium quartiles. In summary, low serum calcium is an independent predictor of adverse outcome in the first 2500 days (about 7 years) after AMI. On later points in time this effect attenuates, so that no more significant differences can be observed.
No takes yet. Share an insight, caveat, or question.
Schmitz et al. (2021) conducted a cohort in Acute myocardial infarction (n=3,732). Low admission serum calcium vs. Normal-high admission serum calcium was evaluated on All-cause mortality (28-2500 days) (HR 1.53, 95% CI 1.19-1.98, p=0.000936). Low admission serum calcium was independently associated with a higher risk of all-cause mortality between 28 and 2500 days after acute myocardial infarction compared to normal-high calcium levels.
Synapse has enriched 10 related papers. Consider them for comparative context: